Company Tagline
Ncardia believes that human stem cell (iPSCs) technologies will bring better therapies to patients faster.
Industry Category
Business Keywords
Company Description
Ncardia is a leading biotechnology research company dedicated to accelerating the development of innovative therapies through human stem cell (iPSC) technologies. With a global presence, including its primary location at Ncardia Leiden, Galileiweg 8, Building BioPartner 1, Leiden, South Holland 2333 BD, NL, Ncardia collaborates with biopharmaceutical companies worldwide to harness the power of stem cell technologies in creating novel therapies across various modalities and stages of development.
Leveraging over a decade of expertise, Ncardia has established the infrastructure to differentiate, manufacture, and characterize high-quality iPSC-derived cell and disease models. The company facilitates disease modeling and high-throughput screening to expedite drug discovery processes. Ncardia is committed to understanding its customers' project plans, addressing their questions, and overcoming challenges by co-developing customized human iPSC-based solutions.
Ncardia's approach empowers advancements in drug discovery and safety pharmacology. The company is dedicated to providing advanced solutions and services to meet the evolving needs of the biotechnology and pharmaceutical sectors. We invite the manager of Ncardia to create a customized and exclusive company showcase and product listing on our platform to further enhance Ncardia's reach and impact.
Ncardia is een toonaangevend biotechnologisch onderzoeksbedrijf dat zich toelegt op het versnellen van de ontwikkeling van innovatieve therapieën door middel van menselijke stamceltechnologieën (iPSC). Met een wereldwijde aanwezigheid, inclusief de hoofdvestiging op Ncardia Leiden, Galileiweg 8, Building BioPartner 1, Leiden, Zuid-Holland 2333 BD, NL, werkt Ncardia samen met biofarmaceutische bedrijven wereldwijd om de kracht van stamceltechnologieën te benutten bij het creëren van nieuwe therapieën in verschillende modaliteiten en ontwikkelingsstadia.
Dankzij meer dan een decennium aan expertise heeft Ncardia de infrastructuur opgezet om hoogwaardige iPSC-afgeleide cel- en ziektemodellen te differentiëren, produceren en karakteriseren. Het bedrijf faciliteert ziektemodellering en high-throughput screening om de processen van geneesmiddelenontdekking te versnellen. Ncardia streeft ernaar de projectplannen van haar klanten te begrijpen, hun vragen te beantwoorden en uitdagingen te overwinnen door samen op maat gemaakte menselijke iPSC-gebaseerde oplossingen te ontwikkelen.
De aanpak van Ncardia maakt vooruitgang mogelijk in de ontdekking van geneesmiddelen en veiligheidsfarmacologie. Het bedrijf zet zich in om geavanceerde oplossingen en diensten te leveren om te voldoen aan de veranderende behoeften van de biotechnologische en farmaceutische sector. We nodigen de manager van Ncardia uit om een aangepaste en exclusieve bedrijfspresentatie en productvermelding op ons platform te creëren om het bereik en de impact van Ncardia verder te vergroten.
Key Personnel / Employees
Compare Companies Side by Side
Compare Ncardia with 3 companies in Biotechnology-Research
| Comparison Field |
NcardiaMain Company |
FUJIFILM Cellular Dy...View Profile |
RoukenBioView Profile |
BientaView Profile |
|---|---|---|---|---|
|
Founded Year
|
— | 2004 | 2015 | 2011 |
|
Company Size
|
— | 51-200 | 51-200 | 11-50 |
|
City
|
Leiden, South Holland | Madison, WI | Motherwell, Scotland | |
|
Country
|
Netherlands | United States | ||
|
Skills & Keywords
Comparing with main company
|
30 Total Skills
iPSC technology
Drug discovery
Stem cell research
Biopharmaceutical
Disease modeling
High-throughput screening
Safety pharmacology
assay development
HTS
drug discovery
safety pharmacology
custom cell lines
CRO
CMO
toxicology
disease modeling
neural efficacy
neurons
assay solutions
ipsc
drug development
neural safety
stem cells
cardiomyocytes
cardiovascular safety
cardiovascular efficacy
fibroblast
astrocytes
electrophysiology
contraction assays
|
9 Total
9 Unique
Unique Skills:
cardiac progenitor cells
custom iPS cell lines
dopaminergic neurons
endothelial cells
hematopoietic progenitor cells
hepatocytes
+3
|
26 Total
26 Unique
Unique Skills:
ADCC
ADCs
antibodytherapeutics
Bioassays
biologics
Biosimilars
+20
|
22 Total
22 Unique
Unique Skills:
ADME/DMPK
ADMET
ADME-Tox
Animal studies
Assay development
Bioanalytical services
+16
|
4
Total Companies2004
Oldest Founded2
Countries87
Unique SkillsSimilar Companies
Other organizations in the same industry
Phathom Pharmaceuticals
Biotechnology-ResearchGoing beyond to advance treatments for patients with acid-related disorders
Electra Therapeutics
Biotechnology-ResearchA unique vision on mastering SIRP. A new way to change lives.
BioVendor Group
Biotechnology-ResearchBridging Science and Diagnostics
Alternative Company Names
This company is also known as